Berlin, 8 May 2012: ICRC-Weyer has enhanced its expert medical data management services in order to strengthen its position as a leading provider of data management services in the market. The services are being delivered by knowledgeable medical staff who are responsible for manual medical data validation, medical coding, planning and organisation of ICRC-Weyer’s specialist medical review services.
“The medical review service contains the review of clinical databases by well-trained medical staff which take place during study conduct or prior to analysis.” says Johann Daniel Weyer, a Managing Director at ICRC-Weyer GmbH. “The medical specialists check and discover medical inconsistencies or implausibilities in the data, providing assistance to study teams and allowing decision makers to reduce potential hazards or provide support in (re)interpreting safety and efficacy data on projects.”
ICRC-Weyer has a broad network of medical experts that specialise in various fields. Together with the supervision from the medical data management services team and their purpose-built tools and custom procedures, the company is able to provide services across a vast range of therapeutic areas.
Medical data management works closely with other departments at ICRC-Weyer, including pharmacovigilance and clinical data management.
Company Profile: ICRC-Weyer is an established all phase contract research organization (CRO) based in Berlin, Germany. The company was founded in 1993 by Prof. Dr. Geerd Weyer and offers services ranging from pre-clinical through to phase IV clinical trials. ICRC-Weyer provides complete turnkey solutions including data management, monitoring and medical review services for all stages of the clinical development process. ICRC-Weyer is involved in several global clinical trials and – through collaboration with strong partners – has established a position at the forefront of the latest developments in the world of clinical research. ICRC-Weyer can support clinical projects at any stage from initial trial inception through to regulatory submission. The experienced team of ICRC-Weyer has substantial expertise in the various divisions of clinical research, which enables the company to offer services from preclinical to phase I-IV, health claim and post-marketing studies for pharmaceutical, biotech and nutrition companies. ICRC-Weyer provides services either separately or as synergistic multi-service packages. These Services include Biostatistics, Clinical/Medical Data Management, Independent Expert Medical Review, Medical Writing, Clinical Monitoring, Pharmacovigilance, Regulatory Services, Scientific Consulting and Study Conduct in cooperation with a Phase I and II Unit. ICRC-Weyer has special expertise in Nutrition, CDISC Data Standards and Medical Review.